LivingGLP1
Study S002404

Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial

ClinicalTrials.gov record

Registration

Registration
NCT07056595
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Status
RECRUITING
Enrollment
30
Start
2025-05-21
Primary completion
2026-05-21
Lead sponsor
Botkin Hospital
Conditions
IgA Nephropathy (IgAN)
Interventions
DRUG:Finerenone
Results posted
FALSE

Registered primary outcomes

  • Median change in albuminuria from baseline [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.